2004
DOI: 10.1016/j.pcad.2003.12.001
|View full text |Cite
|
Sign up to set email alerts
|

Cardioversion of atrial tachyarrhythmias: anticoagulation to reduce thromboembolic complications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2008
2008
2015
2015

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 160 publications
0
1
0
Order By: Relevance
“…Warfarin administration is recommended for at least 3 weeks and 4 weeks before and after elective ECV, respectively, unless the possibility of left atrial (LA) thrombus is excluded by transesophageal echocardiography (TEE) [1–4]. However, the validity of this approach for the use of novel oral anticoagulants (NOACs) is unknown.…”
Section: Introductionmentioning
confidence: 99%
“…Warfarin administration is recommended for at least 3 weeks and 4 weeks before and after elective ECV, respectively, unless the possibility of left atrial (LA) thrombus is excluded by transesophageal echocardiography (TEE) [1–4]. However, the validity of this approach for the use of novel oral anticoagulants (NOACs) is unknown.…”
Section: Introductionmentioning
confidence: 99%